3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Papillomavirus Infections
2
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
3
epigallocatechin gallate
2
artesunic acid
2
artemisinin
2
Transurethral Resection of Prostate
2
Surveys and Questionnaires
2
Papillomavirus Vaccines
2
Cytological Techniques
2
Colposcopy
2
Cisplatin
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
human papillomavirus vaccine, L1 type 16, 18
1
artenimol
1
Vitamin B 12
1
Vaccination
1
Triage
1
Standing Orders
1
Specimen Handling
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Mass Screening
1
Liquid Biopsy
1
Lacteol
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Folic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Papillomavirus Infections
×
artesunic acid
×
Clear all
NCT04098744
2025-10-02
ART-CIN_IIB
Frantz Viral Therapeutics, LLC
Phase 2
Recruiting
78 enrolled
NCT06075264
2025-08-14
ART-VIN IIB
Frantz Viral Therapeutics, LLC
Phase 2
Recruiting
27 enrolled